eXoZymes, Inc.

NASDAQ:EXOZ

Biotechnology

Healthcare
$5.54 +16.75%

+$1.06 today

Market cap
$51.42M
Beta
2.66
P/E (TTM)
-6.5
EPS (TTM)
-$1.14
52W Low $6.33High $18.40

Volume 0.01M

Average 0.01M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$6.50M

FY 2025 · Annual

Investing Cash Flow

-$150,218.00

FY 2025 · Annual

Financing Cash Flow

-$27,709.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(1.21M)(1.4M)(2.04M)(5.86M)(9.16M)
Depreciation & Amortization59.41K147.75K196.94K267.38K(52.91K)
Deferred Income Tax00000
Stock-Based Compensation198.46K216.5K281.54K1.13M1.99M
Change in Working Capital(536.48K)(190.07K)220.31K(4.02M)380.17K
Accounts Receivables(317.07K)(341.18K)(72.79K)145.04K114.72K
Inventory00000
Accounts Payables(214.43K)118.5K272.89K221.34K311.09K
Other Working Capital(4.99K)32.61K20.21K(4.38M)(45.63K)
Other Non-Cash Items(99K)(35.15K)158.73K(19.4K)341.33K
Operating Cash Flow(1.59M)(1.26M)(1.18M)(8.51M)(6.5M)
Capital Expenditures(422.59K)(185.98K)(288.71K)(396.45K)(169.92K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities110.33K98.77K(22.46K)37.24K19.7K
Investing Cash Flow(312.25K)(87.21K)(311.17K)(359.22K)(150.22K)
Debt Repayment0003.98M(27.71K)
Common Stock Issued2.31M1.36M014.53M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities001M11.82K0
Financing Cash Flow2.31M1.36M1M18.52M(27.71K)
Effect of Forex Changes00000
Net Change in Cash413.45K10.76K(492.04K)9.65M(6.68M)
Free Cash Flow(2.01M)(1.44M)(1.47M)(8.9M)(6.67M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$9.2M
+ D&A-$52.9K
+ Stock-Based Comp$2.0M
+ Deferred Tax$0
+ Working Capital$380.2K
+ Other Non-Cash$341.3K
= Operating Cash Flow-$6.5M
- Capex-$169.9K
= Free Cash Flow-$6.7M

Analysis

FY2025 free cash flow is -$6.7M. FCF conversion is 72.8% of net income. Operating cash flow was -$6.5M, with capex of -$169.9K. The largest bridge item is Stock-Based Comp at $2.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 18, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipAug 25, 2026
4Statement of changes in beneficial ownershipAug 25, 2026

Does EXOZ generate free cash flow?

eXoZymes, Inc. (EXOZ) generated -$6.67M of free cash flow in fiscal 2025.

How much operating cash flow does EXOZ produce?

Operating cash flow was -$6.50M, before capital expenditures of $169,917.00.